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Abstract
Background: Glyphosate-based herbicides (GBHs) are the most widely used pesticides worldwide, and glyphosate
is the active ingredient of such herbicides, including the formulation known as Roundup. The massive and
increasing use of GBHs results in not only the global burden of occupational exposures, but also increased exposure to
the general population. The current pilot study represents the first phase of a long-term investigation of GBHs that we are
conducting over the next 5 years. In this paper, we present the study design, the first evaluation of in vivo parameters
and the determination of glyphosate and its major metabolite aminomethylphosphonic acid (AMPA) in urine.
Methods: We exposed Sprague-Dawley (SD) rats orally via drinking water to a dose of glyphosate equivalent to the
United States Acceptable Daily Intake (US ADI) of 1.75 mg/kg bw/day, defined as the chronic Reference Dose (cRfD)
determined by the US EPA, starting from prenatal life, i.e. gestational day (GD) 6 of their mothers. One cohort was
continuously dosed until sexual maturity (6-week cohort) and another cohort was continuously dosed until adulthood
(13-week cohort). Here we present data on general toxicity and urinary concentrations of glyphosate and its major
metabolite AMPA.
Results: Survival, body weight, food and water consumption of the animals were not affected by the treatment with
either glyphosate or Roundup. The concentration of both glyphosate and AMPA detected in the urine of SD rats
treated with glyphosate were comparable to that observed in animals treated with Roundup, with an increase in
relation to the duration of treatment. The majority of glyphosate was excreted unchanged. Urinary levels of the parent
compound, glyphosate, were around 100-fold higher than the level of its metabolite, AMPA.
Conclusions: Glyphosate concentrations in urine showed that most part of the administered dose was excreted as
unchanged parent compound upon glyphosate and Roundup exposure, with an increasing pattern of glyphosate
excreted in urine in relation to the duration of treatment. The adjuvants and the other substances present in Roundup
did not seem to exert a major effect on the absorption and excretion of glyphosate. Our results demonstrate that
urinary glyphosate is a more relevant marker of exposure than AMPA in the rodent model.
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Background
Glyphosate [IUPAC chemical name N-(phosphono-
methyl)glycine] is the most widely applied pesticide
worldwide and it is an active ingredient of all
glyphosate-based herbicides (GBHs), including in the
formulation “Roundup” [1, 2]. It is mainly marketed as a
broad-spectrum systemic herbicide and crop desiccant
[3]. The Asia-Pacific region represents the largest sup-
plier of glyphosate active ingredient worldwide in terms
of production.. In 2016, China contributed the largest
share in the Asia Pacific, and is likely to remain a dom-
inant market for years to come. The United State trails
behind the Asia-Pacific market in the production of
GBHs. Latin America, Middle East and Africa are ex-
pected to grow in terms of use at a significant rate dur-
ing 2017–2025 [4]. Production and use of glyphosate
have risen dramatically with the introduction in 1996 of
genetically modified (GM) glyphosate tolerant crop var-
ieties. In the United States (US) glyphosate is contained
in over 750 products, particularly herbicides used for in-
tensive GM crops that have built-in tolerance to glypho-
sate, but also in other products used in agriculture,
forestry, urban, and home applications [5]. In 2015, 89%
of corn, 94% of soybeans, and 89% of cotton cropped in
the US were genetically modified to be glyphosate-
tolerant [6]. Only a few data on the use of individual
pesticides are available for certain countries in the Euro-
pean Union (EU), making it difficult to find out how
much glyphosate is being used by farmers [7]. However,
surveys in individual countries give some indication.
Glyphosate is the top ranked herbicide in United King-
dom arable crop production [8]. In Denmark, glyphosate
accounts for 35% of all pesticides used in agricultural
production [9]. In Germany, it has been estimated that
glyphosate is used on 4.3 million hectares (39%) of agri-
cultural land each year, with nearly two thirds applied to
just 3 crops - oilseed rape, winter wheat and winter bar-
ley [10]. The EU has a strict regulation regarding the
planting of GM crops (Directive EU 2015/412) [11] and
GBHs are mainly applied to cereals for post-harvest des-
iccation purposes (wheat, rye, triticale, barley and oats),
oilseeds (rapeseed, mustard seed and linseed), orchards
and vineyards [12].
The massive and increasing use of GBHs leads to a
global burden of occupational exposures in manufactur-
ing workers and GBH applicators (farmers), as well as
increasing exposures in the general population, as demon-
strated by environmental contamination from glyphosate
residues found in air [13], groundwater [14, 15], drinking-
water [16], crops [17, 18], food [19, 20] and animal feed
[21]. Microbial biodegradation of glyphosate occurs in soil,
aquatic sediment and water. The main pathway of biodeg-
radation of glyphosate appears to be by splitting the C–N
bond to produce aminomethylphosphonic acid (AMPA),
the major microbial metabolite [22]. In humans, the main
exposure routes to glyphosate are inhalation and dermal
exposure in the occupational setting and consumption of
water and food for the general population [22]. The results
of oral studies with [14C] glyphosate in rats, rabbits and
goats indicate that absorption from the gastrointestinal
tract is incomplete and amounts to up to 30% of the dose
[23–25]. The most relevant routes of excretion following
oral administration of glyphosate [14C] are feces (70–80%)
and urine (20–30%) [26]. In rats, after a single oral
administration of [14C] glyphosate, almost all radioactivity
was detected in urine and feces, and the radiolabeled
detected chemical was present as the unchanged parent
compound [27–29]. Elimination through exhaled air was
very low. AMPA was the only metabolite detected,
accounting for only 0.2–0.3% of the applied dose of [14C]
glyphosate [30]. The limited data currently available on
glyphosate pharmacokinetics in vertebrates are insufficient
to predict transport and fate of glyphosate in different
mammalian tissues, organs and fluids in the body, and to
determine whether or where bioaccumulation occurs,
although animal metabolism studies indicate kidney and
liver as target tissues [1].
The possible effects of GBHs on human health is the
topic of intense public debate, for both its potential car-
cinogenic and non-carcinogenic effects, including endo-
crine disruption, neurotoxicity, developmental and
reproductive toxicity, which might occur even at doses
much lower than the ones considered for risk assess-
ment, in particular during sensitive periods of life (such
as fetal development) [5, 12, 31, 32]. Glyphosate, as the
pure active substance, and GBHs may not be quite the
same from the toxicological standpoint. Glyphosate for-
mulations contain a number of so-called ‘inert’ ingredi-
ents or adjuvants to facilitate the uptake by plants, most
of which are patented and not publicly known (in many
countries the law does not require a full disclosure of
pesticide ingredients). GBHs that contain surfactants
and adjuvants might act differently than glyphosate
alone [33, 34]. In fact, adjuvants might potentiate the
toxic effects of glyphosate [35–38].
The Ramazzini Institute 13-week pilot study: aims and
experimental design
The present pilot study is the first phase of an integrated
long-term project on GBHs that we are conducting dur-
ing the next 5 years [39]. The initial focus of our pilot
study is to assess techniques and methods for glyphosate
detection in different matrices (results presented here),
then to evaluate target organ toxicity, genotoxicity and
endocrine disrupting activities, together with omics and
microbiome alterations (not presented here). In our pilot
study, we exposed Sprague-Dawley (SD) rats to either
glyphosate or Roundup, one of the most popular
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branded GBHs, with a dosage considered to be
“safe”, the United States Acceptable Daily Intake (US
ADI) of 1.75 mg/kg bw/day, defined as the chronic
Reference Dose (cRfD) determined by the US EPA
[40]. The design of the pilot study derives from the
13-week cohort protocol of the National Toxicology
Program (NTP) guideline Modified One-Generation
study (MOG) [39, 41]. It incorporates exposure dur-
ing the perinatal period (i.e., gestation and lactation)
and later for 13 weeks after the pups are weaned,
evaluating standard sub-chronic toxicity and func-
tional endpoints (e.g., sperm analysis, vaginal cy-
tology, indices of puberty and sexual differentiation)
to investigate possible effects on the reproductive
and endocrine systems. In order to provide more in-
formation about specific modes of action, we further
integrated the 13-week cohort NTP MOG design
with transcriptome analyses of potential target tis-
sues and gut microbiome evaluation at different
time-points and life stages in both dams and their
offspring. The whole-transcriptome analysis can pro-
vide important mechanistic information and support
the pathological evaluation of target organs and hor-
mone analysis. The gut microbiome evaluation is a
novel endpoint representing the potential role of al-
tered balance in the gut microbiota that relate to
several health disorders such as metabolic diseases,
hepatic, coronary and gastrointestinal diseases (e.g.,
inflammatory bowel disease) [32]. The experimental
plan and the endpoints investigated in the study are
presented in Table 1 and Table 2.
The protocol of the pilot study commences with
exposure from gestation day (GD) 6 (implantation)
continuously through pregnancy and lactation. To satisfy
the need to consider multiple effects across multiple life
stages, at weaning the offspring were assigned to two
testing cohorts at random, so as to have minimal differ-
ences in body weight among groups (standard deviation
< 10% of the average). The first cohort (6-week cohort)
was continuously dosed until full sexual maturity (Post
Natal Day-PND 73 ± 2), then sacrificed. The second
cohort (13-week cohort) was continuously dosed until
adulthood (PND 125 ± 2), then sacrificed. Both co-
horts were analyzed for post-natal developmental
landmarks, microbiome, target organs toxicity and
clinical pathology.
The design of the pilot study has been developed by
the Ramazzini Institute in collaboration with all Institu-
tions taking part in the overall Glyphosate Study. All of
the in vivo experimental phases of the study were per-
formed at the Ramazzini Institute, while the other col-
laborating Institutions have independently assessed
different outcomes and endpoints of interest. In this
paper, we present the study design, the first evaluation
of in vivo parameters and the determination of glypho-
sate and its major metabolite AMPA in urine.
Methods
Experimental model
The study was conducted following the rules established
by the Italian law regulating the use and humane
treatment of animals for scientific purposes [Decreto
Table 1 Experimental plan
Breeders Offspring
Group Animals Group Animalsa Treatmentb End of the experiment
Sex No. N. Sex Cohort Compound Dosec Age at
startd
Cohort
6-week (No.) 13-week (No.) 6-week (PND) 13-week (PND)
I F 8 I M 8 10 Control
(drinking water)
0 GD 6 70e 120f
M 8 F 8 10
F +M 16 M + F 16 20
II F 8 II M 8 10 Glyphosate US ADI GD 6 70e 120f
M 8 F 8 10
F +M 16 M + F 16 20
III F 8 III F 8 10 Roundup US ADI Glyphosate
equivalent
GD 6 70e 120f
M 8 M 8 10
F +M 16 F +M 16 20
Total M + F 48 M + F 48 60
aNo more than 2 sisters and 2 brothers per litter
bTest compounds are administered ad libitum in drinking water
cDoses are calculated considering the Glyphosate US ADI defined as the chronic Reference Dose (cRfD) determined by the US EPA (1.75 mg/kg bw/day)
dSolutions are admistered to dams starting from the 6th day of pregnancy
eAnimals are treated until the landmarks of sexual development are acquired (PND 73 ± 2)
fAnimals are treated from embryonic life (GD 6) indirectly from dams milk until PND 28 ± 2, then directly for 90 days after weaning (until PND 125 ± 2)
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Legislativo (D.Lgs.) N. 26, 2014. Attuazione della diret-
tiva n. 2010/63/UE in materia di protezione degli animali
utilizzati a fini scientifici. - G.U. Serie Generale, n. 61 del
14 Marzo 2014]. Before starting, the protocol was exam-
ined by the Internal Ethical Committee for approval.
The protocol of the experiment was also approved and
formally authorized by the ad hoc commission of the
Italian Ministry of Health (ministerial approval n. 710/
2015-PR). The experiment was performed on both male
and female SD rats, which belong to the colony used at
the Cesare Maltoni Cancer Research Center laboratories
of the Ramazzini Institute (CMCRC/RI) for over 40 years.
An animal disease screening program enforced by the
Italian Health Authority and Research Organization for
Animal Health is in place and ongoing on sentinel ani-
mals belonging to the RI colony.
Female breeders SD rats were placed individually in
Polycarbonate cage (42x26x18cm; Tecniplast Buguggi-
ate, Varese, Italy) with a single unrelated male until evi-
dence of copulation was observed. After mating,
matched females were housed separately during gesta-
tion and delivery. Newborns were housed with their
Table 2 Summary of the endpoints and relative monitoring time points evaluated in the study, in dams and offspring (6-week and
13-week cohorts)




Gestation length GD0-delivery ✓ – –
AGD and body weight in male and female
pups
PND 1 – ✓ ✓
Litter size PND 1, 4, 7, 10, 13, 16, 19, 21, 25 – ✓ ✓
Live-birth index PND 1 – ✓ ✓
Survival index PND 4, 7, 10, 13, 16, 19, 21, 25 – ✓ ✓
Age and body weight at BPS in male pups PND 35 – ✓ ✓
Age and body weight at VO in female pups PND 28 – ✓ ✓
First estrous in female pups 3 days after VO – ✓ –
Estrous cycle length and percentage of days
in each stage
PND 95 - PND 116 – – ✓
Estrous cycle prior to necropsy PND 125 ± 2 – – ✓
Serum hormone measures End of lactation (dams), PND 73 ± 2 and PND 125 ± 2 ✓ ✓ ✓
Clinical biochemistry PND 73 ± 2 and PND 125 ± 2 – ✓ ✓
Urinalysis PND 73 ± 2 and PND 125 ± 2 – ✓ ✓
Glyphosate and AMPA detection in urine End of lactation (dams), PND 73 ± 2 and PND 125 ± 2 ✓ ✓ ✓
Sperm counts PND 73 ± 2 and PND 125 ± 2 – ✓ ✓
Daily Sperm production PND 73 ± 2 and PND 125 ± 2 – ✓ ✓
Sperm transit time through the epididymis PND 73 ± 2 and PND 125 ± 2 – ✓ ✓
Sperm morphology PND 73 ± 2 and PND 125 ± 2 – ✓ ✓
Sperm aneuploidy PND 73 ± 2 and PND 125 ± 2 – ✓ ✓
Partial histopathology (reproductive organs,
brain, liver, kidney)
End of lactation (dams) ✓ – –
Complete histopathology PND 73 ± 2 and PND 125 ± 2 – ✓ ✓
Organ weight End of lactation (dams), PND 73 ± 2 and PND 125 ± 2 ✓ ✓ ✓
Micronuclei test (bone marrow) PND 73 ± 2 and PND 125 ± 2 – ✓ ✓
Transcriptome on mammary glands End of lactation (dams), PND 73 ± 2 and PND 125 ± 2 ✓ ✓ ✓
Transcriptome on brain PND 125 ± 2 – – ✓
Transcriptome on liver End of lactation (dams), PND 73 ± 2 and PND 125 ± 2 ✓ ✓ ✓
Transcriptome on kidneys End of lactation (dams), PND 73 ± 2 and PND 125 ± 2 ✓ ✓ ✓
Microbiome analysis in dams Before mating, GD 5 (before treatment), GD 13, LD 7, LD 14 ✓ – –
Microbiome analysis in offspring PND 7, PND 14, PND 31 (before puberty), PND 57 (after puberty),
PND 125 ± 2 (adulthood)
– ✓ ✓
GD gestation day, LD lactation day, PND postnatal day, AGD anogenital distance, VO vaginal opening, BPS balano preputial separation
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mothers until weaning. Weaned offspring were housed,
by sex and treatment group, not more than 3 per each
cage. Cages were identified by a card indicating: study
protocol code, experimental and pedigree numbers, dos-
age group. A shallow layer of white fir wood shavings
served as bedding (supplier: Giuseppe Bordignon, Tre-
viso, Italy). Analysis of chemical characteristics (pH,
ashes, dry weight, specific weight) and possible contam-
ination (metals, aflatoxin, polychlorobiphenyls, organo-
phosphorus and organochlorine pesticides) of the
bedding was performed by CONSULAB Laboratories
(Treviso, Italy). The cages were placed on racks, inside a
single room prepared for the experiment at 22 °C ± 3 °C
temperature and 50 ± 20% relative humidity. Daily
checks on temperature and humidity were performed.
The light was artificial and a light/dark cycle of 12 h was
maintained.
During the experiment SD rats received ad libitum the
standard “Corticella” pellet feed supplied by Laboratorio
Dottori Piccioni Srl (Piccioni Laboratory, Milan, Italy).
The constituents of the diet are: ground corn (23%), bar-
ley milled (15%), soybean meal extract (20.6%), wheat
middling (24%), wheat bran (2%), spray dried whey (2.
5%), di-calcium phosphate (2%), calcium carbonate (1.
1%), chicken meal (6%), carob bean gum (3%), sodium
chloride (0.5%), mixed vitamins (0.3%). Every day, the
animals drank fresh municipal tap water from glass bot-
tles ad libitum. Both feed and water were periodically
analyzed to identify possible chemical or microbiological
contaminants or impurities; the analyses are included in
the documentation of the experiment. The pelleted feed
was tested for possible glyphosate contamination in
compliance with Commission Regulation (EU) No 293/
2013 [maximum residue levels (MRLs) < 1 mg/kg]. Tap
drinking water was tested for possible glyphosate con-
tamination in compliance with Directive 2008/105/EC,
D.Lgs. 152/2006, Directive2006/118/EC (active sub-
stances in pesticides, including their relevant metabo-
lites, degradation and reaction products < 0.1 μg/l).
Active ingredient glyphosate (Pestanal™ analytical
standard, CAS number 1071–83-6, purity > 99,5%) was
supplied from Sigma-Aldrich (Milan, Italy). The com-
mercial formulation Roundup Bioflow (containing
360 g/L of glyphosate acid in the form of 480 g/l isopro-
pylamine salts of glyphosate (41.5%), water (42.5%) and
surfactant (16%; chemical name, CAS number and/or
exact percentage have been withheld as a trade secret)
was supplied from a local agricultural consortium (Con-
sorzio Agrario dell’Emilia, Bologna, Italy). The original
containers/bottles of glyphosate and Roundup were
stored in its original container and kept in a ventilated
storage cabinet at room temperature (22 °C ± 3 °C)
throughout the study. Purity data for each batch of gly-
phosate and Roundup were provided by the supplier.
The opening and the use date of the different batches of
test substances were recorded in the raw data. An ali-
quot of each lot of the test article is maintained in the
ventilated storage cabinet, until 5 years from the end of
the main experiment. The solutions of glyphosate and
Roundup were prepared by the addition of appropriate
volume of tap drinking water.
Experimental plan
Each of twenty-four virgin female SD rats (17 weeks old,
270-315 g) was cohabited outbred with one breeder male
rat of the same age and strain. Every day, the females
were examined for presence of sperm. Gestational day
(GD) 0 was defined as the one in which the sperm was
found in vaginal smears. The day on which parturition
was completed was designated as lactating day (LD) 0
for the dam and PND 0 for the offspring. Each dam and
delivered litter was co-housed in common nesting box
during the postpartum period. Following the NTP MOG
design, on PND 28, thus 28 days after the last litter was
delivered, the offspring were weaned and identified by
ear punch according to the Jackson Laboratory system.
Sequentially, they were allocated in the same treatment
group of their mother in order to have 18 males (8 for
the 6-week cohort and 10 for the 13-week cohort) and
18 females (8 for the 6-week cohort and 10 for the 13-
week cohort) for each dose group. No more than 2
males and 2 females from the same litter were included
in the same cohort/treatment group. Altogether, 108 SD
rats (54 males and 54 females) were enrolled in the post-
weaning treatment phase. The experimental plan of the
pilot study is outlined in Table 1. A summary of the end-
points and relative monitoring time points evaluated in
the pilot study, both in dams and in the offspring (6-
week and 13-week cohorts) is presented in Table 2.
Two groups of SD rats were treated with either glyphosate
or Roundup diluted in tap water administered ad libitum and
one group received only tap water as control. Roundup was
diluted in tap water in order to obtain an equivalent dose of
glyphosate of 1.75 mg/kg bw/day. During gestational and lac-
tational periods, embryos and newborns (F1) received the test
compounds mainly through their dams (F0). Glyphosate and
Roundup water formulations during these periods were
freshly prepared on a daily base depending on individual
body weight and water consumption of dams as measured at
each scheduled time point (see below). After weaning, until
the end of the experiment (PND 73± 2 or 125 ± 2), the test
substances were administered in tap water to F1 animals on
the basis of the average body weight and average water con-
sumption per sex and per experimental group, as measured
at each scheduled time point (see below). Males and females
were considered separately because of their difference in
weight gain, body weight and water consumption.
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At least every week, the exposure doses were recalcu-
lated and registered. The actual levels of test compounds
that reached the fetus during gestation or that were
ingested postnatally by the offspring during the period
of lactation were not estimated in the present study.
Animals were monitored during the entire experimen-
tal period. The following procedures were performed:
Health status control: from the start of the experiment,
animals were checked three times daily, except on Sun-
days and non-working days, when they were only
checked twice. All observed variations from normal sta-
tus were recorded.
Clinical control: status, behavior and clinical observation
on the experimental animals were checked before the start
of the treatment, and at least every two days until the end
of the experiment. Any findings listed below were then re-
corded: alterations of skin, hair, eyes and mucosa; modifi-
cation in production of secretions or excretions and in
autonomic activity; respiratory symptoms; postural
changes or changes in walk; presence of tonic or clonic
contractions; unusual stereotypes and behavior.
Dams’ body weights were recorded on GD 0, 3, 6 and
then daily during gestation until parturition. During lac-
tation, dams’ body weights were recorded at LD 1, 4, 7,
10, 13, 16, 19, 21 and 25 (last measurement before wean-
ing). Pups’ body weight by sex and litter was determined
on PND 1, 4, 7, 10, 13, 16, 19, 21 and 25. After weaning,
the body weight was measured twice a week, until PND
73 ± 2, then weekly until PND 125 ± 2 and before ter-
minal sacrifices; the means of individual body weights
were calculated for each group and sex.
Dams’ feed and water consumption were recorded
twice weekly during gestation (GD 0, 3, 6, 9, 12, 15, 18,
21), whereas during lactation were measured at LD 1, 4,
7, 10, 13, 16, 19, 21, 25 and 28.
After weaning the daily water and feed consumption
per cage were measured twice a week, until PND 73 ± 2,
then weekly until PND 125 ± 2; the means of individual
consumptions were calculated for each group and sex.
The day before the terminal sacrifices, all the animals
were located individually in metabolic cages and starved for
around 16 h. During this time, the animals had free access
to water alone or to the programmed test compound solu-
tions. The day after, in the morning, samples of at least
5 ml of spontaneous urine from each animal were collected
and put in separate labelled tubes. Urine samples for ana-
lysis of glyphosate and AMPA excretion were obtained
from 3 dams/group and from 10 (5 males + 5 females) rats/
group belonging to the 6-week and 13-week cohorts.
Glyphosate and aminomethylphosphonic acid (AMPA)
detection
Analyses of glyphosate and its metabolite AMPA in
drinking water, feed and urine were performed by
Neotron Laboratories (Modena, Italy), an officially accre-
dited laboratory by Accredia (Lab. N. 0026) according to
European regulation UNI CEI EN ISO/IEC 17025:2005.
The specification and results are maintained in the experi-
mental documentation. The analytical method is based on
liquid chromatography tandem mass spectrometry (LC-
MS/MS) [42–45]. The limit of quantification (LQ) for gly-
phosate and AMPA corresponded to 0.10 μg/l in water,
50 μg/kg in feed, and 1 μg/kg in urine.
Statistical analysis
Summary statistics, means ± standard deviations (sd),
were calculated for continuous variables. For body
weight, water and feed consumption over time further
analyses were performed using multilevel mixed-effect
linear regression models, to control for within subject
correlation across time; moreover we have considered
also the litter effect during the lactation period. Analysis
of variance and Dunnett’s tests (when applicable) were
also performed to compare body weight gain in different
periods and consumption of food and water as mean
consumption in several periods.
All tests were two tailed, with alpha set at 0.05. Statis-
tical analyses were perfomed by using STATA version10
(Stata Corporation, College StationTexas, USA).
Results
In dams, during both gestation and lactation, body
weight and weight gain were not statistically different
among the different groups (Fig. 1 a-b). In both female
and male offspring, post weaning body weights were
homogenous and no statistically significant differences
in body weight gain were observed among groups (Fig. 1
c-f). All 24 dams and 108 SD rats from the 6-week (48/
48) and 13-week (60/60) cohorts survived until sacrifice.
Water and feed consumption during gestation and lac-
tation were no different across the groups (Fig. 2 a-b
and Fig. 3 a-b). Litter sizes were fully comparable among
groups, with mean number of live pups: control group
13.6 (range 10–16); glyphosate group 13.3 (range 11–
17); Roundup group 13.9 (range 11–16). Post weaning
water and feed consumption were not affected by the
treatment (Fig. 2 c-d and Fig. 3 c-d).
No unexpected clinical signs or symptoms were ob-
served in the experimental animals during the in vivo
phase. In particular, there was no clinical evidence of al-
terations in activity or behavior, reflexes, the eye or skin,
or the respiratory, gastrointestinal, genito-urinary and
cardiovascular systems.
The results of glyphosate and AMPA urinary concen-
trations are reported in Table 3 and Fig. 4. The urinary
concentration of both glyphosate and AMPA of SD rats
treated with 1.75 mg/kg bw/day of glyphosate were com-
parable to the ones observed in SD rats treated with
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Roundup dose equivalent to 1.75 mg/kg bw/day, despite
limited sample size and the large standard deviations. In
the control group, as expected, the glyphosate and
AMPA urinary levels were all below or close to the limit
of quantitation (0.001 mg/kg). In the treated SD rats, the
majority of glyphosate was excreted unchanged (as par-
ent compound), with urinary levels about 100-fold
higher than that of its metabolite AMPA. For example,
Fig. 1 Average body weight: dams during gestation (a), treatment starting at gestation day 6 (↓); dams (b), male (c) and female (d) offspring
during lactation; male (e) and female (f) offspring after weaning. At week 6 after weaning 8 male and 8 female pups per group were sacrificed
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glyphosate and Roundup treated females in the 13-week
cohort presented mean urinary levels of glyphosate re-
spectively of 1.354 mg/kg and 1.524 mg/kg, while the
AMPA levels were respectively 0.013 mg/kg and 0.
021 mg/kg. In glyphosate and Roundup treated SD rats,
a time-dependent increase in the mean urinary concen-
tration of glyphosate was observed. In glyphosate and
Roundup treated males, an approximate 2-fold in-
crease of mean urinary concentration of glyphosate in
the 13-week cohort (animals exposed prenatally until
125 ± 2 days after birth) compared to the 6-week cohort
(animals exposed prenatally until 73 ± 2 days after birth)
was observed. In glyphosate treated females, the 6-week
cohort (animals exposed prenatally until 73 ± 2 days
after birth) showed a 2-fold higher value of mean urinary
concentration of glyphosate than the dams after weaning
(exposed for 49 ± 2 days), while the 13-week cohort (ani-
mals exposed prenatally and 125 ± 2 days after birth)
showed a 1.5-fold increase compared to the 6-week
cohort. In the Roundup treatment group, the increase was
less steep, but the time-dependent pattern was still evi-
dent. In glyphosate and Roundup treated SD rats, the
levels of AMPA were comparable at the different time
points in both males and females. In these animals, large
standard deviations of the values of AMPA concentrations
in urine have been observed, in particular for values close
to the limit of quantitation as in the control groups.
Discussion
Survival, body weights, food and water consumption of
SD rats were not affected by the treatment with glypho-
sate and Roundup. Clinical changes in the animals were
not observed in the various groups. Overall, both gly-
phosate and Roundup treatments seemed to be well tol-
erated, which is consistent with previous experiments
performed by the US NTP [26].
Glyphosate and Roundup exposure led to comparable
concentrations of glyphosate and AMPA in urine,
Fig. 2 Average water consumption: dams during gestation (a), treatment starting at gestation day 6 (↓); dams and litter (b) during lactation; male
(c) and female (d) offspring after weaning. At week 6 after weaning 8 male and 8 female pups per group were sacrificed
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indicating that systemic exposure does occur at the se-
lected exposure level of 1.75 mg//kg bw/day, corre-
sponding to the US ADI. The bioavailability of
glyphosate in our study is also supported by the evident
increase of glyphosate concentration in urine in relation
to the length of treatment. The adjuvants and the other
substances present in Roundup did not seem to exert a
major effect on the absorption and excretion of glypho-
sate, even though mean values of glyphosate seem to be
somewhat higher in the Roundup treated group. The
levels in urine were also comparable between the two
sexes; however, a consistent inter-individual variability
was observed. In rats, glyphosate in urine appears to be
the most accurate biomarker of exposure to GBHs. In
Fig. 3 Average feed consumption: dams during gestation (a), treatment starting at gestation day 6 (↓); dams and litter (b) during lactation; male
(c) and female (d) offspring after weaning. At week 6 after weaning 8 male and 8 female pups per group were sacrificed
Table 3 Glyphosate and AMPA concentration in urine. Results are reported as mean ± standard deviations
Dams Offspring (6-week cohort) Offspring (13-week cohort)
Treatment Glyphosate AMPA Glyphosate AMPA Glyphosate AMPA
(mg/kg) (mg/kg) (mg/kg) (mg/kg) (mg/kg) (mg/kg)
Male Control 0.012 ± 0.010 0.003 ± 0.003 0.011 ± 0.010 0.006 ± 0.004
Glyphosate _ _ 0.938 ± 0.414 0.014 ± 0.007 1.684 ± 0.768 0.023 ± 0.012
Roundup 1.174 ± 0.439 0.011 ± 0.005 2.280 ± 1.520 0.027 ± 0.016
Female Control 0.009 ± 0.001 0.006 ± 0.002 0.013 ± 0.007 0.005 ± 0.001 0.008 ± 0.005 0.003 ± 0.005
Glyphosate 0.480 ± 0.010 0.024 ± 0.002 0.938 ± 0.377 0.016 ± 0.010 1.354 ± 0.359 0.013 ± 0.006
Roundup 0.700 ± 0.106 0.024 ± 0.001 0.910 ± 0.383 0.018 ± 0.007 1.524 ± 0.585 0.021 ± 0.007
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fact, our results confirm previous evidence that in rodents
most of the administered dose of glyphosate (98%) is
excreted as unchanged parent compound, whereas the
metabolite AMPA in urine is at around 0.2–0.3% of the
administered dose [46]. Furthermore, with the level of ex-
posure to glyphosate used in this pilot study, AMPA urin-
ary values of treated animals (0.011–0.027 mg/kg) were
already close to the chromatographic LQ (0.001 mg/kg)
Fig. 4 Average urinary concentrations of glyphosate and AMPA, expressed in mg/kg, collected at terminal sacrifices. Dams glyphosate (a) and
AMPA (b) excretion; 6-week cohort male and female offspring; glyphosate (c) and AMPA (d) excretion; 13-week cohort male and female pups
Glyphosate (e) and AMPA (f) excretion
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and this might limit the reliability of the measures. On the
other hand, glyphosate concentration in urine of treated
animals (0.480–2.280 mg/kg) resulted up to 100-fold
higher than the AMPA concentration and at least 500-
fold higher than the chromatographic LQ (0.001 mg/kg).
Therefore, in order to assess exposure to glyphosate in
rats, in particular at doses that are equal or lower than
the one used in this pilot study (1.75 mg/kg bw/day),
glyphosate appears to be the biomarker of choice.
The presence of negligible levels of glyphosate (0.003–
0.013 mg/kg), close to the chromatographic LQ (0.001
mg/kg), in some of the urine of the control groups might
reflect an ubiquitous environmental contamination at
ultra-low doses of glyphosate, which is consistent with
previous reports from other authors [21]. As the current
limit of quantitation of glyphosate in HPLC for pelleted
animal feed is 0.050 mg/kg, this represents a technical
limiting factor for testing ultra-low doses of glyphosate.
As reported by a recent inter laboratory comparative study
on the quantitative determination of glyphosate at low
levels, caution should be taken when interpreting results if
the tested doses of glyphosate are close to the LQ of
HPLC [47].
It is noteworthy that the commercial formulation used
in this study, Roundup Bioflow, was the representative
formulated product recently evaluated for the renewal of
the approval of glyphosate in EU and considered in the
European Food Safety Authority peer review (MON
52276) [48].
Our results seem particularly relevant in light of the
massive global burden of exposure to glyphosate, as shown
by the exponential increase in the last 20 years of the levels
of glyphosate and AMPA measured in the urine of the
general population in Germany [49] and in the US [50].
Conclusion
We performed a pilot study on the health effects of gly-
phosate and its formulation Roundup administered at
currently admitted doses (US ADI = 1.75 mg/kg bw/day)
to SD rats. In this paper, we described the study design,
the first evaluation of in vivo parameters and the deter-
mination of glyphosate and its major metabolite AMPA
in urine. The treatment with either glyphosate or
Roundup seemed to be overall well tolerated, consist-
ently with previous experiments performed by the US
NTP [26]. Both glyphosate and Roundup exposure led
to comparable urinary concentrations of glyphosate and
AMPA with an increasing pattern of glyphosate excreted
in urine in relation to the duration of treatment, indicat-
ing the systemic bioavailability of the active sub-
stance and a possible mechanism of bioaccumulaton.
The adjuvants and the other substances present in
Roundup did not seem to exert a major effect on the ab-
sorption and excretion of glyphosate. Our results
confirm that, in rodents, glyphosate in urine is the much
more relevant marker of exposure than AMPA in par-
ticular at doses that are equal or lower than the one used
in this pilot study (1.75 mg/kg bw/day). The evaluation
of different outcomes and endpoints of interest (i.e.,
pathology of target organs, molecular toxicity, genotoxi-
city, endocrine disrupting activities, microbiome, devel-
opmental toxicity, etc.) is currently ongoing in the
different partner laboratories of the project.
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